Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Tomasson · SciRah

Researcher profile · Semantic Scholar

M. Tomasson

Share profile

M. Tomasson — researcher profile on SciRah

h-index: 48
Works: 211
Citations: 22K

Most-cited papers

TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes
J. Welch, A. Petti, Christopher A. Miller, C. Fronick +35 more
2016New England Journal of Medicine749 citations Open access
Semantic Scholar
Elranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial results
A. Lesokhin, M. Tomasson, B. Arnulf, N. Bahlis +25 more
2023Nature Medicine613 citations Open access
Semantic Scholar
SciClone: Inferring Clonal Architecture and Tracking the Spatial and Temporal Patterns of Tumor Evolution
Christopher A. Miller, B. S. White, N. Dees, M. Griffith +13 more
2014PLoS Comput. Biol.447 citations Open access
Semantic Scholar
Elranatamab in relapsed or refractory multiple myeloma: the MagnetisMM-1 phase 1 trial
N. Bahlis, Caitlin L. Costello, N. Raje, M. Levy +15 more
2023Nature Medicine143 citations Open access
Semantic Scholar
Socioeconomic Status is Independently Associated with Overall Survival in Patients with Multiple Myeloma
M. Fiala, Joseph D Finney, Jingxia Liu, K. Stockerl-Goldstein +3 more
2015Leukemia and Lymphoma67 citations Open access
Semantic Scholar
Radionuclides transform chemotherapeutics into phototherapeutics for precise treatment of disseminated cancer
N. Kotagiri, M. Cooper, M. Rettig, C. Egbulefu +17 more
2018Nature Communications65 citations Open access
Semantic Scholar
Efficacy and Safety of Elranatamab in Patients with Relapsed/Refractory Multiple Myeloma Naïve to B-Cell Maturation Antigen (BCMA)-Directed Therapies: Results from Cohort a of the Magnetismm-3 Study
N. Bahlis, M. Tomasson, M. Mohty, R. Niesvizky +18 more
2022Blood52 citations Open access
Semantic Scholar
A multiple myeloma-specific capture sequencing platform discovers novel translocations and frequent, risk-associated point mutations in IGLL5
B. S. White, Irena Lanc, J. O'Neal, Harshath Gupta +14 more
2018Blood Cancer Journal50 citations Open access
Semantic Scholar
Ex Vivo and In Vivo Evaluation of Overexpressed VLA-4 in Multiple Myeloma Using LLP2A Imaging Agents
Deepti Soodgupta, Hai-Ying Zhou, W. Beaino, Lan Lu +9 more
2016Journal of Nuclear Medicine49 citations Open access
Semantic Scholar
Small Molecule MYC Inhibitor Conjugated to Integrin-Targeted Nanoparticles Extends Survival in a Mouse Model of Disseminated Multiple Myeloma
Deepti Soodgupta, D. Pan, Grace Cui, A. Senpan +6 more
2015Molecular Cancer Therapeutics49 citations Open access
Semantic Scholar
The skinny on obesity and plasma cell myeloma: a review of the literature
K. Carson, Melissa L. Bates, M. Tomasson
2014Bone Marrow Transplantation49 citations Open access
Semantic Scholar
Elranatamab (PF-06863135), a B-Cell Maturation Antigen (BCMA) Targeted CD3-Engaging Bispecific Molecule, for Patients with Relapsed or Refractory Multiple Myeloma: Results from Magnetismm-1
M. Sebag, N. Raje, N. Bahlis, C. Costello +16 more
2021Blood47 citations Open access
Semantic Scholar
Comparative Effectiveness on Survival of Zoledronic Acid versus Pamidronate in Multiple Myeloma
K. Sanfilippo, B. Gage, S. Luo, K. Weilbaecher +4 more
2014Leukemia and Lymphoma45 citations Open access
Semantic Scholar
Identification and Characterization of Tumor-Initiating Cells in Multiple Myeloma.
Min-Jie Gao, H. Bai, Y. Jethava, Yu-Jie Wu +17 more
2019Journal of the National Cancer Institute42 citations Open access
Semantic Scholar
Elranatamab, a BCMA Targeted T-Cell Engaging Bispecific Antibody, Induces Durable Clinical and Molecular Responses for Patients with Relapsed or Refractory Multiple Myeloma
N. Raje, N. Bahlis, C. Costello, B. Dholaria +15 more
2022Blood41 citations Open access
Semantic Scholar
Acute myeloid leukemia resistant to venetoclax-based therapy: What does the future hold?
P. Dhakal, Melissa L. Bates, M. Tomasson, G. Sutamtewagul +2 more
2022Blood reviews39 citations
Semantic Scholar
Contact-facilitated drug delivery with Sn2 lipase labile prodrugs optimize targeted lipid nanoparticle drug delivery
D. Pan, C. Pham, K. Weilbaecher, M. Tomasson +2 more
2015Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology35 citations Open access
Semantic Scholar
Efficacy and safety of elranatamab (PF-06863135), a B-cell maturation antigen (BCMA)-CD3 bispecific antibody, in patients with relapsed or refractory multiple myeloma (MM).
N. Bahlis, N. Raje, C. Costello, B. Dholaria +16 more
202132 citations
Semantic Scholar
Whole Genome Sequence of Multiple Myeloma-Prone C57BL/KaLwRij Mouse Strain Suggests the Origin of Disease Involves Multiple Cell Types
Sarah R. Amend, W. Wilson, L. Chu, Lan Lu +14 more
2015PLoS ONE32 citations Open access
Semantic Scholar
A meta-analysis of genome-wide association studies of multiple myeloma among men and women of African ancestry.
Zhao-Hui Du, N. Weinhold, G. Song, K. Rand +66 more
2020Blood Advances31 citations Open access
Semantic Scholar
NEK2 induces osteoclast differentiation and bone destruction via heparanase in multiple myeloma
M. Hao, R. Franqui-Machin, H. Xu, J. Shaughnessy +10 more
2017Leukemia30 citations Open access
Semantic Scholar
A strategy for combating melanoma with oncogenic c-Myc inhibitors and targeted nanotherapy
D. Pan, Benjamin Kim, G. Hu, Deepti Gupta +7 more
2015Nanomedicine27 citations
Semantic Scholar
A meta-analysis of multiple myeloma risk regions in African and European ancestry populations identifies putatively functional loci
K. Rand, Chi Song, Eric Déan, D. Serie +98 more
2016Cancer Epidemiology, Biomarkers and Prevention26 citations Open access
Semantic Scholar
Collaborative Control of Cell Cycle Progression by the RNA Exonuclease Dis3 and Ras Is Conserved Across Species
Mark Snee, W. Wilson, Yi Zhu, Shin-Yu Chen +7 more
2016Genetics24 citations Open access
Semantic Scholar
Myeloma cell dynamics in response to treatment supports a model of hierarchical differentiation and clonal evolution
Min Tang, Rui-Ting Zhao, H. Van de Velde, Jennifer G Tross +10 more
2016Clinical Cancer Research24 citations Open access
Semantic Scholar
Next Generation Sequencing-based Validation of the Revised International Staging System for Multiple Myeloma: An Analysis of the MMRF CoMMpass Study.
S. Goldsmith, M. Fiala, James Dukeman, A. Ghobadi +5 more
2019Clinical Lymphoma, Myeloma & Leukemia21 citations
Semantic Scholar
The snoRNA target of t(4;14) in multiple myeloma regulates ribosome biogenesis
Vanessa Oliveira, N. Mahajan, Melissa L. Bates, Chakrapani Tripathi +4 more
2019FASEB bioAdvances20 citations Open access
Semantic Scholar
Elranatamab, a B-cell maturation antigen (BCMA)-CD3 bispecific antibody, for patients (pts) with relapsed/refractory multiple myeloma (RRMM): Extended follow up and biweekly administration from the MagnetisMM-3 study.
M. Mohty, M. Tomasson, B. Arnulf, N. Bahlis +16 more
2023Journal of Clinical Oncology18 citations Open access
Semantic Scholar
Upregulation of FOXM1 in a subset of relapsed myeloma results in poor outcome
C. Gu, Carol J. Holman, R. Sompallae, X. Jing +8 more
2018Blood Cancer Journal18 citations Open access
Semantic Scholar
Elranatamab, a BCMA-targeted T-cell redirecting immunotherapy, for patients with relapsed or refractory multiple myeloma: Updated results from MagnetisMM-1.
A. Jakubowiak, N. Bahlis, N. Raje, C. Costello +16 more
2022Journal of Clinical Oncology16 citations
Semantic Scholar
Initial safety results for MagnetisMM-3: A phase 2 trial of elranatamab, a B-cell maturation antigen (BCMA)-CD3 bispecific antibody, in patients (pts) with relapsed/refractory (R/R) multiple myeloma (MM).
A. Lesokhin, B. Arnulf, R. Niesvizky, M. Mohty +12 more
2022Journal of Clinical Oncology16 citations
Semantic Scholar
Prevention Is the Best Treatment: The Case for Understanding the Transition from Monoclonal Gammopathy of Undetermined Significance to Myeloma
M. Tomasson, Mahmoud Ali, Vanessa de Oliveira, Q. Xiao +4 more
2018International Journal of Molecular Sciences16 citations Open access
Semantic Scholar
Re: Disparities in Utilization of Autologous Hematopoietic Cell Transplantation for Treatment of Multiple Myeloma.
M. Fiala, Joseph D Finney, K. Stockerl-Goldstein, M. Tomasson +3 more
2015Biology of Blood and Marrow Transplantation16 citations Open access
Semantic Scholar
The characteristics and outcomes of patients with multiple myeloma dual refractory or intolerant to bortezomib and lenalidomide in the era of carfilzomib and pomalidomide
Tzu-Fei Wang, R. Ahluwalia, M. Fiala, K. Trinkaus +8 more
2013Leukemia and Lymphoma13 citations Open access
Semantic Scholar
Computational Model of Progression to Multiple Myeloma Identifies Optimum Screening Strategies
Philipp M. Altrock, Jeremy Ferlic, T. Galla, M. Tomasson +1 more
2018JCO Clinical Cancer Informatics12 citations Open access
Semantic Scholar
Sabotaging of the oxidative stress response by an oncogenic noncoding RNA
N. Mahajan, Hua-Jun Wu, Richard L. Bennett, C. Troche +4 more
2017The FASEB Journal12 citations Open access
Semantic Scholar
The Real-World Characteristics and Outcomes of Newly Diagnosed Myeloma Patients Ineligible for Clinical Trials
M. Fiala, James Dukeman, K. Stockerl-Goldstein, M. Tomasson +2 more
201612 citations
Semantic Scholar
Sex Differences in Cardiovascular Disease and Dysregulation in Down Syndrome.
Melissa L. Bates, A. Vasileva, Laura D. M. Flores, Yana Pryakhina +3 more
2023American Journal of Physiology. Heart and Circulatory Physiology10 citations Open access
Semantic Scholar
Deletion of Rb1 induces both hyperproliferation and cell death in murine germinal center B-cells
Zhi-Wen He, J. O'Neal, W. Wilson, N. Mahajan +7 more
2015Experimental Hematology10 citations Open access
Semantic Scholar
Elevated IgM and abnormal free light chain ratio are increased in relatives from high-risk chronic lymphocytic leukemia pedigrees
M. Glenn, M. Madsen, Ethan Davis, Cassandra Garner +5 more
2019Blood Cancer Journal9 citations Open access
Semantic Scholar
Chronic intermittent hypoxia enhances disease progression in myeloma-resistant mice.
Mahmoud Ali, Sandeep Kowkuntla, Derick J Delloro, C. Galambos +9 more
2019American Journal of Physiology. Regulatory Integrative and Comparative Physiology8 citations Open access
Semantic Scholar
SEA-BCMA, an Investigational Nonfucosylated Monoclonal Antibody: Ongoing Results of a Phase 1 Study in Patients with Relapsed/Refractory Multiple Myeloma (SGNBCMA-001)
J. Hoffman, B. Lipe, J. Melear, M. Liedtke +9 more
2021Blood7 citations Open access
Semantic Scholar
Utilizing digital pathology and immunohistochemistry of p53 as an adjunct to molecular testing in myeloid disorders
Kai J. Rogers, I. Abukhiran, S. Syrbu, M. Tomasson +3 more
2023Academic Pathology6 citations Open access
Semantic Scholar
S196: ELRANATAMAB, A B-CELL MATURATION ANTIGEN (BCMA)-CD3 BISPECIFIC ANTIBODY, FOR PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: EXTENDED FOLLOW UP AND BIWEEKLY ADMINISTRATION FROM MAGNETISMM-3
M. Mohty, M. Tomasson, B. Arnulf, N. Bahlis +15 more
2023HemaSphere6 citations Open access
Semantic Scholar
Osteolytic disease in IL-6 and Myc dependent mouse model of human myeloma
Fumou Sun, Yan Cheng, S. Walsh, M. Acevedo +8 more
2019Haematologica5 citations Open access
Semantic Scholar
A Single Autologous Stem Cell Transplant (ASCT) Followed By Two Years of Post-Transplant Therapy in Recently Diagnosed Elderly Multiple Myeloma (MM) Patients. Safety and Response Results from the Prospective Phase II Trial (NCT01849783)
Kalyan Nadiminti, C. Strouse, Praveen Vikas, Lindsay Dozeman +9 more
2018Blood5 citations
Semantic Scholar
MM-379: MagnetisMM-1: A Study of Elranatamab (PF-06863135), a B-Cell Maturation Antigen (BCMA)-Targeted, CD3-Engaging Bispecific Antibody, for Patients with Relapsed or Refractory Multiple Myeloma (MM)
M. Levy, N. Bahlis, N. Raje, C. Costello +16 more
20214 citations
Semantic Scholar
Wearable Monitors Facilitate Exercise in Adult and Pediatric Stem Cell Transplant
Ethan Pottebaum, Alexa Warmoth, S. Ayyappan, David S. Dickens +5 more
2021Exercise and sport sciences reviews4 citations Open access
Semantic Scholar
Ex Vivo Evaluation of VLA-4 Expression in Primary Human Multiple Myeloma Bone Marrow Samples and In Vivo Mobilization of Murine Multiple Myeloma Cells with Small Molecule VLA-4 Inhibitors
C. Chanswangphuwana, M. Rettig, W. Akers, D. Hathi +9 more
20164 citations
Semantic Scholar
Treatment Advances for Multiple Myeloma Have Disproportionally Benefited Patients Who Are Young, White, and Have Higher Socioeconomic Status
M. Fiala, J. Keller, K. Stockerl-Goldstein, M. Tomasson +2 more
20144 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

R. Vij×13
Invite
R. Vij — researcher profile on SciRah
A. Lesokhin×11
Invite
A. Lesokhin — researcher profile on SciRah
N. Bahlis×11
Invite
N. Bahlis — researcher profile on SciRah
N. Raje×11
Invite
N. Raje — researcher profile on SciRah

×8

Invite

M. Fiala — researcher profile on SciRah

K. Stockerl-Goldstein×7

Invite

K. Stockerl-Goldstein — researcher profile on SciRah

Invite

J. Dipersio — researcher profile on SciRah

Invite

Y. Jethava — researcher profile on SciRah

Melissa L. Bates×7

Invite

Melissa L. Bates — researcher profile on SciRah

Invite

M. Solh — researcher profile on SciRah

Invite

C. Basu — researcher profile on SciRah

Invite

A. Skoura — researcher profile on SciRah